Andrea Knezevic joined Memorial Sloan Kettering in February 2017, following 8 years of research at the Emory University Department of Biostatistics & Bioinformatics. Andrea has experience in design, implementation and analysis of phase II clinical trials, as well as retrospective and prospective observational studies. Her analytical expertise is in survival analysis and model building for explanatory and predictive modeling.
Patel RM, Knezevic A, Shenvi N, Hinkes MT, Keene S, Roback JD, Easley KA, Josephson CD. (2016). Association of Red Blood Cell Transfusion, Anemia and Necrotizing Enterocolitis in Very Low Birth Weight Infants. Journal of the American Medical Association, 315(9):889-897.
Ofotokun I, Titanji K, Lahiri CD, Vunnava A, Foster A, Sanford SE, Sheth AN, Lennox JL, Knezevic A, Ward L, Easley KA, Powers, P, Weitzmann MN. (2016). A Single Dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-Induced Bone Loss in Treatment-naïve HIV-infected Patients: a Phase IIb Trial. Clinical Infectious Diseases, 63(5):663-671.
Josephson CD, Caliendo AM, Easley KA, Knezevic A, Shenvi N, Hinkes MT, Patel RM, Hillyer CD and Roback JD. (2014). Blood Transfusion and Breast Milk Transmission of Cytomegalovirus in Very Low-Birth-Weight Infants. Journal of the American Medical Association Pediatrics, 168(11):1054-1062.